JCVI advice on the 2023 COVID-19 vaccination programme
The Joint Committee on Vaccination and Immunisation (JCVI) has published a statement with its latest advice on the 2023 programme. Whilst there is high level of strong population immunity developed over the past two and a half years, the risk of severe COVID-19 continues to be disproportionately greater in those from older age groups, residents in care homes for older adults, and persons with certain underlying health conditions. There also still remains on-going uncertainty regarding virus evolution, the durability and breadth of immunity, and the epidemiology of infection. The JCVI has indicated that for a smaller group of persons (such [...]







